Exelixis, Inc. today announced its preliminary unaudited financial results for the fiscal year 2025, provided financial guidance for fiscal year 2026 and delivered an update on its business. Exelixis ...
Dr. Thejus Jayakrishnan sat down with CURE at the 2026 ASCO Gastrointestinal Cancers Symposium to discuss research he ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback